← All medicines
CRYSVITA 20 mg solution for injection
Licence EU/1/17/1262/002 · Unknown
- Licence holder
- Kyowa Kirin Holdings B.V. (all products →)
- Active substance
- Recombinant human igg1 monoclonal antibody to fibroblast growth factor 23
- Dosage form
- Solution for injection
- Route of administration
- Subcutaneous use
- ATC codes
- M05BX, M05BX05
- First authorised
- 19/02/2018
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.